Detalles de la búsqueda
1.
How I use risk factors for success or failure of CD19 CAR T cells to guide management of children and AYA with B-cell ALL.
Blood
; 141(11): 1251-1264, 2023 03 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36416729
2.
Impact of poverty and neighborhood opportunity on outcomes for children treated with CD19-directed CAR T-cell therapy.
Blood
; 141(6): 609-619, 2023 02 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36351239
3.
Absolute lymphocyte count recovery following initial acute myelogenous leukemia therapy: Implications for adoptive cell therapy.
Pediatr Blood Cancer
; 70(1): e30062, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36370087
4.
Presentation acuity, induction mortality, and resource utilization in infants with acute leukemia.
Pediatr Blood Cancer
; 68(7): e28940, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33704911
5.
Driving two chimeric antigen receptors (CARs) in a row to reduce antigen escape in B-cell acute lymphocytic leukaemia.
Lancet Oncol
; 24(11): 1163-1164, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37863087
6.
Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma.
Cancer
; 124(4): 816-825, 2018 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-29125192
7.
Prospective, longitudinal assessment of quality of life in children from diagnosis to 3 months off treatment for standard risk acute lymphoblastic leukemia: Results of Children's Oncology Group study AALL0331.
Int J Cancer
; 138(2): 332-9, 2016 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26235006
8.
A prospective study of anxiety, depression, and behavioral changes in the first year after a diagnosis of childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Cancer
; 120(9): 1417-25, 2014 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24473774
9.
Reinfusion of CD19 CAR T cells for relapse prevention and treatment in children with acute lymphoblastic leukemia.
Blood Adv
; 8(9): 2182-2192, 2024 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38386999
10.
Household income and health-related quality of life in children receiving treatment for acute myeloid leukemia: Potential impact of selection bias in health equity research.
Cancer Med
; 13(7): e6966, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38572962
11.
INSPIRED Symposium Part 1: Clinical Variables Associated with Improved Outcomes for Children and Young Adults treated with Chimeric Antigen Receptor T cells for B cell Acute Lymphoblastic Leukemia.
Transplant Cell Ther
; 29(10): 598-607, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37481241
12.
Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cells.
Blood Adv
; 7(4): 575-585, 2023 02 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-35482927
13.
Rachitic changes, demineralization, and fracture risk in healthy infants and toddlers with vitamin D deficiency.
Radiology
; 262(1): 234-41, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22106354
14.
Statistical Considerations for Analyses of Time-To-Event Endpoints in Oncology Clinical Trials: Illustrations with CAR-T Immunotherapy Studies.
Clin Cancer Res
; 28(18): 3940-3949, 2022 09 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35838646
15.
Single-cell antigen-specific landscape of CAR T infusion product identifies determinants of CD19-positive relapse in patients with ALL.
Sci Adv
; 8(23): eabj2820, 2022 06 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35675405
16.
Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALL.
J Clin Oncol
; 40(9): 932-944, 2022 03 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34767461
17.
Single-cell multiomics dissection of basal and antigen-specific activation states of CD19-targeted CAR T cells.
J Immunother Cancer
; 9(5)2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34006631
18.
Integrative Bulk and Single-Cell Profiling of Premanufacture T-cell Populations Reveals Factors Mediating Long-Term Persistence of CAR T-cell Therapy.
Cancer Discov
; 11(9): 2186-2199, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33820778
19.
Risk-Adapted Preemptive Tocilizumab to Prevent Severe Cytokine Release Syndrome After CTL019 for Pediatric B-Cell Acute Lymphoblastic Leukemia: A Prospective Clinical Trial.
J Clin Oncol
; 39(8): 920-930, 2021 03 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33417474
20.
Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic Leukemia.
J Clin Oncol
; 39(27): 3044-3055, 2021 09 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34156874